Clinical Trials Browser

Interventional × Breast Neoplasms × Drug Therapy × Clear all

NCT03424005 2026-03-16

Morpheus-panBC

Phase 1/2 Recruiting

Breast Neoplasms

NCT01928589 2026-03-06

Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer

Phase NA Active not recruiting

Breast Neoplasms

NCT07378306 2026-01-30

FACT-TN

Phase 2 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07372079 2026-01-28

Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With Chemotherapy

Phase 2 Not yet recruiting

Breast Neoplasms

NCT05826964 2026-01-13

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

Phase 2 Active not recruiting

Breast Neoplasms

NCT06195709 2025-12-18

ECLECTIC

Phase 3 Recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT00929214 2025-12-17

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

Phase 2 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT06635980 2025-12-12

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03283384 2025-09-19

NEOLBC

Phase 2 Active not recruiting

Breast Neoplasms

NCT07152938 2025-09-15

AVR-CHEMO

Phase NA Completed

BreastGastrointestinalLymphoidPlasma cell

Agnosia, Anxiety Disorders, Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms

NCT07161791 2025-09-09

Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer

Phase 1/2 Not yet recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07137793 2025-08-22

PTX / BC

Phase 2 Recruiting

Breast Neoplasms

NCT02276443 2025-08-01

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Phase NA Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06678048 2025-06-06

Arsenous Acid for Refractory Triple-Negative Breast Cancer

Phase 2 Recruiting

Breast Neoplasms

NCT07005557 2025-06-05

SENIOR

Phase 3 Not yet recruiting

Breast Neoplasms

NCT06642441 2025-01-17

Effect of Vitamin D Supplementation on Chemotherapy Side Effects After Adjuvant Chemotherapy for Breast Cancer

Phase NA Recruiting

Breast Neoplasms

NCT06727357 2024-12-10

Next Generation Sequencing-based "Oncochip" for Therapeutic Decision in Metastatic Breast Cancer. Study SHARP

Phase 2 Active not recruiting

Breast Neoplasms

NCT03227328 2024-11-07

KENDO

Phase 2 Completed

Breast Neoplasms

NCT06438055 2024-05-31

Clinical Treatment of Refractory Breast Cancer Based on Organoid Drug Sensitivity Results

Phase NA Not yet recruiting

Breast Neoplasms

NCT02448420 2024-04-18

PATRICIA II

Phase 2 Completed

Breast Neoplasms

NCT06341621 2024-04-10

Rainbow

Phase 3 Recruiting

Breast Neoplasms

NCT03329950 2024-03-28

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Phase 1 Completed

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Bile Duct Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Liver Neoplasms, Lung Neoplasms, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Lymphoma, Large B-Cell, Diffuse, Cholangiocarcinoma, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Hyper-IgM Immunodeficiency Syndrome

NCT05143970 2024-03-20

CHANCES

Phase 1 Unknown

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT06165900 2024-01-03

Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC

Phase 2 Recruiting

Breast Neoplasms

NCT05862610 2023-07-24

The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC

Phase 2 Not yet recruiting

Breast Neoplasms

NCT02679040 2023-07-03

HIST-RIC

Phase 2 Unknown

Breast Neoplasms

NCT05840068 2023-05-03

IGF Level in Breast Cancer Patients Treated With Metformin

Phase 4 Completed

Breast Neoplasms

NCT00004935 2023-04-18

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

Phase 3 Terminated

Breast Neoplasms

NCT03386162 2022-11-28

SAFIR-PI3K

Phase 2 Terminated

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT02000596 2022-05-27

1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.

Phase 2 Terminated

2 enrolled 7 charts

Breast Neoplasms

NCT05346861 2022-04-26

Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab

Phase 3 Unknown

Breast Neoplasms

NCT04004910 2022-03-24

A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients

Phase 1/2 Unknown

Breast Neoplasms

NCT05253066 2022-02-23

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

Phase 2/3 Unknown

Breast Neoplasms

NCT04143282 2021-12-07

Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment

Phase 2 Completed

Breast Neoplasms

NCT02535221 2021-11-29

Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

Phase 3 Recruiting

Breast Neoplasms

NCT03908528 2021-10-11

Alpha-Lipoic Acid in Breast Cancer Patients

Phase NA Completed

Breast Neoplasms

NCT04559308 2020-09-22

The Effect of Metformin on Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms

NCT01104935 2019-10-21

RESPECT

Phase 3 Completed

Breast Neoplasms

NCT02457039 2019-05-20

Acupuncture Prevents Chemobrain in Breast Cancer Patients

Phase NA Completed

Breast Neoplasms, Cognitive Dysfunction, Drug-Related Side Effects and Adverse Reactions

NCT03907098 2019-04-08

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT03175341 2018-06-27

Intravenous Ascorbic Acid Supplementation in Neoadjuvant Chemotherapy for Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms

NCT01796444 2018-04-05

Z0011-China

Phase 3 Withdrawn

Breast Neoplasms

NCT01712009 2018-01-30

NOLAN

Phase 2 Completed

600 enrolled 15 charts

Breast Neoplasms

NCT03242551 2017-11-14

BINC-B

Phase 2 Unknown

Breast Neoplasms

NCT00382018 2017-11-06

S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo

Phase 3 Completed

624 enrolled 12 charts

Breast Neoplasms

NCT00074152 2017-06-16

CALOR

Phase 3 Completed

162 enrolled 17 charts

Breast Neoplasms

NCT00584766 2015-05-29

Intensive Combo Chemo With Autologous BM Rescue for Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT01368263 2015-04-03

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer

Phase 2 Terminated

8 enrolled 5 charts

Breast Neoplasms

NCT00448279 2014-10-24

THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.

Phase 3 Completed

58 enrolled 11 charts

Breast Neoplasms

NCT01928615 2014-09-29

LISAH

Phase 2 Terminated

2 enrolled 3 charts

Breast Neoplasms